Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s):  N.MMED.WS | N.MMED.WA | N.MMED.WR | N.MMED

Healthcare
Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen... see more

NDAQ:MNMD - Post Discussion

Mind Medicine (MindMed) Inc > Ladies more competition but this time it’s a real pharma
View:
Post by elgin1 on Dec 08, 2020 9:40am

Ladies more competition but this time it’s a real pharma

Rumour has it Mindmend was trying to buy their drug.

https://www.stockwatch.com/News/Item?bid=Z-C:BETR-3002453&symbol=BETR&region=C
Comment by mrBlockchain on Dec 08, 2020 10:11am
I'm buying; with only C$40m mkt cap BETR looks cheap
Comment by goldmike on Dec 08, 2020 10:57am
  Betterlife Pharma to acquire Transcend Biodynamics   2020-12-08 10:18 ET - News Release   Dr. Ahmad Doroudian reports BETTERLIFE ADDS NEXT-GEN PSYCHEDELIC THERAPY TO ITS PIPELINE OF DRUGS Betterlife Pharma Inc. has signed a definitive agreement to acquire 100 per cent of the assets in Transcend Biodynamics LLC valued at $10-million in an all-stock transaction for a ...more  
Comment by elgin1 on Dec 08, 2020 12:18pm
Is Mindmned drug able to be synthesized? Why aren't they going after US market ? I think that is the key .  How does Berger Life's drug compare to mmeds's promotional drug ? 
Mind Medicine (MindMed) Inc